Adenoviral vector expressing CYLD augments antitumor activity of TRAIL by suppression of NF-kappaB survival signaling in hepatocellular carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/16627981

Download in:

View as

General Info

PMID
16627981